Advertisement
Home Tags Multiple Sclerosis

Tag: Multiple Sclerosis

For patients with relapsing-remitting multiple sclerosis

Enhanced Atypical Lymphocytes in Natalizumab-Treated MS

0
Enhanced fraction of atypical lymphocytes, especially binucleated and plasmacytoid lymphocytes
A pharmacist medication adherence program can improve adherence to interferon-beta among patients with relapsing-remitting multiple sclerosis

Pharmacist Program Can Improve IFN-β Adherence in MS

0
Increase in patient knowledge scores from baseline to end of third visit at three months
A genetic variant that is associated with both multiple sclerosis and systemic lupus erythematosus has been identified

Genetic Variant Tied to MS and Systemic Lupus Identified

0
However, BAFF variant was likely selected over time as an adaptive response to malaria
An experimental immune-system therapy appears safe for patients with progressive forms of multiple sclerosis

AAN: Early Research Promising for Immunotherapy in MS

0
Investigators employ the relationship between MS and Epstein-Barr virus
Circulating exosomes have a distinct RNA profile in relapsing-remitting multiple sclerosis

Circulating Exosomes Have Distinct RNA Profile in MS

0
Serum exosomal expression of four microRNAs significantly decreased during relapse
Cannabidiol may reduce seizures in patients with Lennox-Gastaut syndrome

AAN: Cannabis-Based Medicine May Help Tough-to-Treat Epilepsy

0
Cannabidiol appears to lessen drop seizures for some Lennox-Gastaut syndrome patients
Maternal and perinatal factors that influence the risk of pediatric multiple sclerosis include cesarean delivery and maternal health during pregnancy

C-Section, Maternal Health Impact Odds of Pediatric MS

0
Possible association for pesticide-related environmental exposures with pediatric-onset MS
The intravenous drug Ocrevus (ocrelizumab) has been approved by the U.S. Food and Drug Administration to treat adults with primary progressive multiple sclerosis and relapsing forms of the disease

FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis

0
First drug sanctioned in United States for primary progressive multiple sclerosis
An invasive multiple sclerosis treatment called liberation therapy is not only costly

SIR: ‘Liberation Therapy’ Ineffective As MS Treatment

0
Invasive procedure carries risk of complications, significant financial cost, researcher says
Multiple sclerosis is more likely to progress to advanced disease among patients who suffer from fatigue and limited use of their legs

AAN: Certain Symptoms Predictive of Worsening MS

0
Fatigue, limited leg function tied to progressive disease